Treatment of HNSCC cell lines with the EGFR-specific inhibitor cetuximab (Erbitux®) results in paradox phosphorylation of tyrosine 1173 in the receptor

✍ Scribed by Robert Mandic; Chantal J. Rodgarkia-Dara; Li Zhu; Benedikt J. Folz; Michael Bette; Eberhard Weihe; Andreas Neubauer; Jochen A. Werner

• Book ID: 118441941
• Publisher: Elsevier Science
• Year: 2006
• Tongue: English
• Weight: 495 KB
• Volume: 580
• Category: Article
• ISSN: 0014-5793
• DOI: 10.1016/j.febslet.2006.07.064